NHRI Enters Technology Transfer Agreement of DBPR186 with Taivex Therapeutics Corp. IBPR 2022-01-05 2022-01-05News & Events National Health Research Institutes (NHRI) and Tai… Continue reading
Congratulation to DBPR807 team on receiving the 18th National Innovation Award in the Academic Research Category IBPR 2022-01-05 2022-01-05Awards & Honors “Development of CXCR4-Targeting Antagonists for Ac… Continue reading
Congratulation to DBPR807 team on receiving the 18th National Innovation Award in the Academic Research Category IBPR 2022-01-05 2022-01-05未分類 “Development of CXCR4-Targeting Antagonists for Ac… Continue reading
Congratulation to DBPR211 team on receiving the 18th National Innovation Award in the Renewal and Issue the Excelsior Award IBPR 2022-01-04 2022-01-05Awards & Honors “Discovery and development of novel anti-diabetic … Continue reading
NHRI Enters Technology Transfer Agreement of DBPR114 with LaunXP Biomedical Co., Ltd. IBPR 2021-11-26 2022-03-29News & Events National Health Research Institutes (NHRI) and Lau… Continue reading
NHRI Enters Technology Transfer Agreement of DBPR215 with Jiayi Biomedical Co., Ltd. IBPR 2021-08-16 2021-08-16News & Events National Health Research Institutes (NHRI) and Jia… Continue reading
National Health Research Institutes Announces the Initiation of Phase I Clinical Trial of DBPR115, A Novel Small-molecule Drug Conjugate (SMDC), in Taiwan IBPR 2021-08-16 2021-08-16News & Events With budget supporting from Ministry of Economic A… Continue reading
NHRI Enters Technology Transfer Agreement of DBPR211 with Applied Biopharma LLC, wholly owned by Agentix Corp. (AGTX) in the US IBPR 2021-08-06 2021-10-12News & Events National Health Research Institutes (NHRI) and App… Continue reading
Congratulations! Dr. Ta-Yuan Chang is elected as a member of the U.S. National Academy of Sciences. IBPR 2021-04-27 2021-04-28News & Events We are honored to announce a good news that Profes… Continue reading
A Safer Opioid Painkiller with Low Side-Effects─NHRI has discovered a series of opioid receptor/nociception receptor dual agonists with fast and potent antinociception, fewer side-effects than morphine IBPR 2020-11-23 2020-11-23News & Events The Ministry of Science and Technology has present… Continue reading
